Intranet PAC-CI
FR EN
PAC-CI Logo PAC-CI Contact us
PAC-CI Logo PAC-CI
Contact us

Blue November: PAC-CI mobilizes for men's health and prostate cancer screening

En valorisation

MODERATO

MODERATO project logo

Project Details

Principal Investigator

  • Sud (Serge Eholié), Nord (Roland Landman)

Chef de Projet

  • Fatou Fadiga

Participating Countries

  • Ivory Coast
  • Cameroon
  • Burkina Faso

Duration

72 months

Sponsor

ANRS MIE

Research Team

The research team has not yet been filled in for this project.

Collaborate with us

We are open to partnerships with international research institutions and doctoral students.

Research Request

Estimated response time: 3-5 business days.

Keywords

OPERATIONS RESEARCH OUR PROJECTS COHORTE

Objectives

Main Objectives
To demonstrate the non-inferiority at 96 weeks of a strategy involving a switch to a two-drug regimen consisting of DTG + 3TC or ATV/r + 3TC compared with the WHO-recommended triple-therapy regimen of TDF + 3TC + EFV or DTG in patients who have maintained virologic success for at least two years on TDF + XTC + EFV or DTG
Exploration

Discover other projects

Tous les projets